Company Filing History:
Years Active: 2007-2011
Title: Innovator Michele Heffernan: Advancing Neuropharmacology
Introduction
Michele Heffernan is a distinguished inventor based in Worcester, MA, known for her impactful contributions to the field of neuropharmacology. With four patents to her name, she plays a crucial role in developing solutions aimed at enhancing cognitive function and treating various neurodegenerative diseases.
Latest Patents
Heffernan's latest patents focus on Pyrrole and Pyrazole DAAO inhibitors, which are methods designed to increase D-Serine concentration while reducing the toxic byproducts of D-Serine oxidation. These innovative methods hold promise for enhancing learning, memory, and cognition. They also aim to tackle serious conditions such as schizophrenia, Alzheimer's disease, ataxia, and neuropathic pain. The patent outlines the administration of a therapeutically effective amount of a compound, or its pharmaceutically acceptable salts or solvates, to individuals in need of treatment, potentially preventing loss in neuronal function associated with neurodegenerative diseases.
Career Highlights
Michele Heffernan has made significant strides in her career at Sepracor, Inc., contributing her expertise to groundbreaking research and development projects. Her work has not only advanced the understanding of D-Serine but also paved the way for potential new therapies in treating complex neurological conditions.
Collaborations
Throughout her career, Heffernan has collaborated with notable colleagues such as Q Kevin Fang and Seth C Hopkins. These partnerships have fostered an environment of creativity and innovation, further enhancing the impact of her work in the pharmaceutical industry.
Conclusion
Michele Heffernan's pioneering contributions to neuropharmacology exemplify the power of innovation in addressing challenging health issues. With her patents focusing on critical advancements in treatment methods for cognitive disorders, she continues to inspire the next generation of inventors and researchers. Her work at Sepracor, Inc. signifies the vital role of collaboration and creativity in fostering breakthroughs in medicine.